Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lung Neoplasms × Doxorubicin × Clear all

Sponsor

Conditions

Breast Neoplasms 89 Lymphoma 58 Lymphoma, Large B-Cell, Diffuse 43 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Sarcoma 31 Lymphoma, Non-Hodgkin 27 Hodgkin Disease 23 Leukemia 20 Burkitt Lymphoma 20 Lymphoma, Mantle-Cell 18 Neoplasms 16 Triple Negative Breast Neoplasms 14 Lymphoma, Follicular 14 Lymphoma, B-Cell 12 Carcinoma, Hepatocellular 12 Lymphoma, Large-Cell, Anaplastic 11 Neuroblastoma 10 Multiple Myeloma 10 Breast Neoplasms, Male 10 Neoplasm Metastasis 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Ovarian Neoplasms 8 Lymphoma, T-Cell, Peripheral 7 Lymphoma, T-Cell 7 Inflammatory Breast Neoplasms 7 Urinary Bladder Neoplasms 6 Osteosarcoma 6 Liposarcoma 6 Leiomyosarcoma 6 Fallopian Tube Neoplasms 6

Interventions

Carboplatin 89 Pemetrexed 65 Paclitaxel 50 Erlotinib Hydrochloride 46 Cisplatin 46 Radiotherapy 45 Docetaxel 37 Gemcitabine 34 Bevacizumab 32 pembrolizumab 25 Nivolumab 23 Radiosurgery 18 Etoposide 18 durvalumab 12 Cetuximab 12 Ipilimumab 11 Albumin-Bound Paclitaxel 10 Vinorelbine 9 Taxes 9 Gefitinib 9 Radiation 8 Magnetic Resonance Spectroscopy 8 osimertinib 7 Specimen Handling 7 Platinum 7 Cyclophosphamide 7 Biopsy 7 130-nm albumin-bound paclitaxel 7 vandetanib 6 epacadostat 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡